Opposition states question vaccine safety at meeting with PM Modi

Echoing the views of Opposition-ruled states that have questioned the emergency use authorisation given to Bharat Biotech’s Covaxin without phase-III trials being completed, Banerjee pointed out that doubts had been expressed about the vaccines as the efficacy data had not been put out in public domain.
Read More

Leave a Comment

Your email address will not be published. Required fields are marked *